Study #2019-1061
Evaluation of a causal association between testosterone levels, dementia, and adverse mental health outcomes: A Mendelian randomization analysis.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
This study evaluates the association between testosterone levels and risk of dementia and adverse mental health outcomes (e.g. depression and anxiety). It is not known whether low testosterone levels may be associated with an increased risk of dementia. Learning about the association between testosterone levels and risk of dementia may help determine the long-term effects of androgen deprivation therapy and may help improve quality of life.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Anxiety Disorder;Depression;Genetic Disorder;Hematopoietic and Lymphoid Cell Neoplasm;Malignant Solid Neoplasm
Study phase:
Physician name:
Kevin Nead
Department:
Epidemiology
For general questions about clinical trials:
1-866-467-0332
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.